Translational and therapeutic potential of oxytocin as an anti-obesity strategy: Insights from rodents, nonhuman primates and humans
Open accessThe DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index.
Abstract
The fact that more than 78 million adults in the US are considered overweight or obese highlights the need to develop new, effective strategies to treat obesity and its associated complications, including type 2 diabetes, kidney disease and cardiovascular disease. While the neurohypophyseal peptide oxytocin (OT) is well recognized for its peripheral effects to stimulate uterine contraction during parturition and milk ejection during lactation, release of OT within the brain is implicated in prosocial behaviors and in the regulation of energy balance. Previous findings indicate that chronic administration of OT decreases food intake and weight gain or elicits weight loss in diet-induced obese (DIO) mice and rats. Furthermore, chronic systemic treatment with OT largely reproduces the effects of central administration to reduce weight gain in DIO and genetically obese rodents at doses that do not appear to result in tolerance. These findings have now been recently extended to more translational models of obesity showing that chronic subcutaneous or intranasal OT treatment is sufficient to elicit body weight loss in DIO nonhuman primates and pre-diabetic obese humans. This review assesses the potential use of OT as a therapeutic strategy for treatment of obesity in rodents, nonhuman primates, and humans, and identifies potential mechanisms that mediate this effect.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Child abuse: Adolescent records vs. adult recall
Femina, D. D., Yeager, C. A., & Lewis, D. O. (1990) · Child Abuse & Neglect · doi:10.1016/0145-2134(90)90033-p · Cited by 8,820
A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis
Boström, P., Wu, J., Jedrychowski, M. P., Korde, A., Ye, L., Lo, J. C., Rasbach, K. A., Boström, E. A., Choi, J. H., Long, J. Z., et al. (2012) · Nature · doi:10.1038/nature10777 · Cited by 4,810
The oxytocin receptor system: structure, function, and regulation
Gimpl, G., & Fahrenholz, F. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.629 · Cited by 3,089
Cornier, M.-A., Dabelea, D., Hernandez, T. L., Lindstrom, R. C., Steig, A. J., Stob, N. R., Van Pelt, R. E., Wang, H., & Eckel, R. H. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0024 · Cited by 2,162
Intake of sugar-sweetened beverages and weight gain: a systematic review
Malik, V. S., Schulze, M. B., & Hu, F. B. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/84.2.274 · Cited by 2,100
Obesity is associated with hypothalamic injury in rodents and humans.
Thaler, J. P., Yi, C.-X., Schur, E. A., Guyenet, S. J., Hwang, B. H., Dietrich, M. O., Zhao, X., Sarruf, D. A., Izgur, V., Maravilla, K. R., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59660 · Cited by 1,857
Self-citationStanhope, K. L., Schwarz, J. M., Keim, N. L., Griffen, S. C., Bremer, A. A., Graham, J. L., Hatcher, B., Cox, C. L., Dyachenko, A., Zhang, W., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37385 · Cited by 1,765
Sugar-Sweetened Beverages, Obesity, Type 2 Diabetes Mellitus, and Cardiovascular Disease Risk
Malik, V. S., Popkin, B. M., Bray, G. A., Després, J.-P., & Hu, F. B. (2010) · Circulation · doi:10.1161/circulationaha.109.876185 · Cited by 1,641
FGF21 regulates PGC-1α and browning of white adipose tissues in adaptive thermogenesis
Fisher, F. M., Kleiner, S., Douris, N., Fox, E. C., Mepani, R. J., Verdeguer, F., Wu, J., Kharitonenkov, A., Flier, J. S., Maratos-Flier, E., et al. (2012) · Genes & Development · doi:10.1101/gad.177857.111 · Cited by 1,478
Sniffing neuropeptides: A transnasal approach to the human brain
Born, J., Lange, T., Kern, W., McGregor, G. P., Bickel, U., & Fehm, H. L. (2002) · Nature Neuroscience · doi:10.1038/nn0602-849 · Cited by 1,356
Tolvaptan, a Selective Oral Vasopressin V 2 -Receptor Antagonist, for Hyponatremia
Schrier, R. W., Gross, P., Gheorghiade, M., Berl, T., Verbalis, J. G., Czerwiec, F. S., & Orlandi, C. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa065181 · Cited by 1,215 · cited 1×
“While combination therapies that include V2R antagonists are effective in correcting hyponatremia in humans [236,237], further studies will be important to determine whether hyponatremia is a potential side effect during chronic OT treatment.”
BackgroundSawchenko, P. E., & Swanson, L. W. (1982) · Journal of Comparative Neurology · doi:10.1002/cne.902050306 · Cited by 1,150
Dietary fat intake does affect obesity!
Bray, G. A., & Popkin, B. M. (1998) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/68.6.1157 · Cited by 1,123 · cited 1×
“Future investigations should examine if intermittent or pulsatile delivery [83,196–201] of OT will extend its effectiveness and circumvent reductions in OTR binding known to occur in the CNS following chronic infusions [170,171].”
BackgroundDeconstruction of a neural circuit for hunger
Atasoy, D., Betley, J. N., Su, H. H., & Sternson, S. M. (2012) · Nature · doi:10.1038/nature11270 · Cited by 969
Long-term Drug Treatment for Obesity: A Systematic and Clinical Review
Yanovski, S. Z., & Yanovski, J. A. (2014) · JAMA · doi:10.1001/jama.2013.281361 · Cited by 876
Diabetes and obesity: the twin epidemics
Smyth, S., & Heron, A. (2006) · Nature Medicine · doi:10.1038/nm0106-75 · Cited by 643
Yoshida, M., Takayanagi, Y., Inoue, K., Kimura, T., Young, L. J., Onaka, T., & Nishimori, K. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5593-08.2009 · Cited by 608 · cited 5×
“1) as well as the existence of OTRs in POMC neurons in the ARC of a reporter knock-in mouse line (OxtrVenusΔNeo/+) where the OTR gene was replaced with Venus cDNA (an enhanced yellow fluorescent protein) [71].”
BackgroundInfluentialHavel, P. J. (2005) · Nutrition Reviews · doi:10.1111/j.1753-4887.2005.tb00132.x · Cited by 607
Increased brain and plasma oxytocin after nasal and peripheral administration in rats and mice
Neumann, I. D., Maloumby, R., Beiderbeck, D. I., Lukas, M., & Landgraf, R. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.03.003 · Cited by 511 · cited 2×
“However, the extent to which this effect is due to elevations in exogenous or endogenous OT is being debated [162,210].”
BackgroundModulation of Blood Pressure by Central Melanocortinergic Pathways
Greenfield, J. R., Miller, J. W., Keogh, J. M., Henning, E., Satterwhite, J. H., Cameron, G. S., Astruc, B., Mayer, J. P., Brage, S., See, T. C., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0803085 · Cited by 477
Striepens, N., Kendrick, K. M., Hanking, V., Landgraf, R., Wüllner, U., Maier, W., & Hurlemann, R. (2013) · Scientific Reports · doi:10.1038/srep03440 · Cited by 452 · cited 2×
“In contrast, intranasal administration of OT, at a dose that reduced total caloric intake [34] and cookie consumption [35] and increased circulating levels of OT in other studies [167,168], failed to reduce plasma ghrelin [34,35], suggesting that this mechanism is not likely to contribute to the anorexigenic response…”
BackgroundOxytocin and Vasopressin Agonists and Antagonists as Research Tools and Potential Therapeutics
Manning, M., Misicka, A., Olma, A., Bankowski, K., Stoev, S., Chini, B., Durroux, T., Mouillac, B., Corbani, M., & Guillon, G. (2012) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2012.02303.x · Cited by 423 · cited 2×
“One potential concern is whether chronic OT, at doses that elicit weight loss, may also interact with vasopressin 2 receptors (V2Rs) in sufficient concentrations to cause hyponatremia (serum sodium 135 mmol/L) [234].”
BackgroundPage, K. A., Chan, O., Arora, J., Belfort-DeAguiar, R., Dzuira, J., Roehmholdt, B., Cline, G. W., Naik, S., Sinha, R., Constable, R. T., et al. (2013) · JAMA · doi:10.1001/jama.2012.116975 · Cited by 379
Loup, F., Tribollet, E., Dubois-Dauphin, M., & Dreifuss, J. J. (1991) · Brain Research · doi:10.1016/0006-8993(91)90345-v · Cited by 378
Oxytocin, motherhood and bonding
Kendrick, K. M. (2000) · Experimental Physiology · doi:10.1111/j.1469-445x.2000.tb00014.x · Cited by 378
Oxytocin–dopamine interactions mediate variations in maternal behavior in the rat
Shahrokh, D. K., Zhang, T.-Y., Diorio, J., Gratton, A., & Meaney, M. J. (2010) · Endocrinology · doi:10.1210/en.2009-1271 · Cited by 366
Kim, F., Pham, M., Maloney, E., Rizzo, N. O., Morton, G. J., Wisse, B. E., Kirk, E. A., Chait, A., & Schwartz, M. W. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.169722 · Cited by 364 · cited 2×
“Previous findings indicate that inflammatory responses within the mediobasal hypothalamus, particularly in ARC POMC neurons [186], occur much sooner than in peripheral tissues and precede the majority of weight gain during the course of diet-induced obesity [185,186].”
BackgroundMens, W. B. J., Witter, A., & Van Wimersma Greidanus, T. B. (1983) · Brain Research · doi:10.1016/0006-8993(83)90478-x · Cited by 360
A review of safety, side-effects and subjective reactions to intranasal oxytocin in human research
MacDonald, E., Dadds, M. R., Brennan, J. L., Williams, K., Levy, F., & Cauchi, A. J. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2011.02.015 · Cited by 359
Blevins, J. E., Schwartz, M. W., & Baskin, D. G. (2004) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00604.2003 · Cited by 332 · cited 1×
“Impairments of OT signaling have been associated with increased consumption of carbohydrate-rich chow [31,32,36,79,80,82,106,119,120], sucrose [107,121–124], fructose [122], and glucose [86,122], as well as fat [31,32] in mice or rats, implicating a physiological role of endogenous OT to reduce intake of fat and sugar.”
BackgroundSelf-citationInfluence of oxytocin on feeding behavior in the rat
Arletti, R., Benelli, A., & Bertolini, A. (1989) · Peptides · doi:10.1016/0196-9781(89)90082-x · Cited by 328 · cited 1×
“Impairments of OT signaling have been associated with increased consumption of carbohydrate-rich chow [31,32,36,79,80,82,106,119,120], sucrose [107,121–124], fructose [122], and glucose [86,122], as well as fat [31,32] in mice or rats, implicating a physiological role of endogenous OT to reduce intake of fat and sugar.”
BackgroundRing, R. H., Malberg, J. E., Potestio, L., Ping, J., Boikess, S., Luo, B., Schechter, L. E., Rizzo, S., Rahman, Z., & Rosenzweig-Lipson, S. (2006) · Psychopharmacology · doi:10.1007/s00213-005-0293-z · Cited by 319 · cited 1×
“In addition to the presence of OTRs in adipocytes, the existence of OTRs elsewhere in the periphery, specifically the GI tract [59–61,152–154], the enteric nervous system [60,152], smooth muscle cells [61,152] and the vagus nerve [60], raises the possibility that circulating OT, in addition to actions at central OTRs…”
BackgroundOxytocin receptor-deficient mice developed late-onset obesity
Takayanagi, Y., Kasahara, Y., Onaka, T., Takahashi, N., Kawada, T., & Nishimori, K. (2008) · Neuroreport · doi:10.1097/wnr.0b013e3283021ca9 · Cited by 294
Prosocial effects of oxytocin and clinical evidence for its therapeutic potential
Striepens, N., Kendrick, K. M., Maier, W., & Hurlemann, R. (2011) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2011.07.001 · Cited by 283 · cited 1×
“While the neurohypophyseal peptide oxytocin (OT) is well recognized for its role in lactation [18], uterine contraction [19], osmoregulation [20], and prosocial behavior [21,22], it has attracted interest as a therapeutic strategy to treat schizophrenia [21,23], autism spectrum disorder [21,22,24,25], and obesity [26–…”
BackgroundImmunohistochemical localization of oxytocin receptors in human brain
Boccia, M. L., Petrusz, P., Suzuki, K., Marson, L., & Pedersen, C. A. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.08.048 · Cited by 276
A conditional knockout mouse line of the oxytocin receptor
Lee, H.-J., Caldwell, H. K., Macbeth, A. H., Tolu, S. G., & Young, W. S. (2008) · Endocrinology · doi:10.1210/en.2007-1710 · Cited by 269
Bales, K. L., Perkeybile, A. M., Conley, O. G., Lee, M. H., Guoynes, C. D., Downing, G. M., Yun, C. R., Solomon, M., Jacob, S., & Mendoza, S. P. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.08.025 · Cited by 265
Mechanisms of the anti-obesity effects of oxytocin in diet-induced obese rats
Deblon, N., Veyrat-Durebex, C., Bourgoin, L., Caillon, A., Bussier, A.-L., Petrosino, S., Piscitelli, F., Legros, J.-J., Geenen, V., Foti, M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025565 · Cited by 254 · cited 8×
“Furthermore, chronic OT central or systemic infusions in vivo result in decreases in fat mass in mice and rats [27,28,30,32,62,93], including the adipocyte area from mesenteric [28], epididymal [28,62,151], subcutaneous [93], perirenal [93] and epicardiac [93] fat depots.”
BackgroundResultInfluentialChang, S. W. C., Barter, J. W., Ebitz, R. B., Watson, K. K., & Platt, M. L. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1114621109 · Cited by 252 · cited 2×
“Regardless, it is encouraging that the intranasal route of administration has yielded positive prosocial effects in nonhuman primates [208], male and female individuals with schizophrenia [227,228], and inmen andwomenwho experience social rejection [229].”
BackgroundLow sympathetic tone and obese phenotype in oxytocin-deficient mice
Camerino, C. (2009) · Obesity · doi:10.1038/oby.2009.12 · Cited by 235 · cited 5×
“For example, global deficiencies in either OT [90] or OTRs [91] are associated with adult-onset obesity in mice.”
BackgroundInfluentialKievit, P., Halem, H., Marks, D. L., Dong, J. Z., Glavas, M. M., Sinnayah, P., Pranger, L., Cowley, M. A., Grove, K. L., & Culler, M. D. (2013) · Diabetes · doi:10.2337/db12-0598 · Cited by 231 · cited 1×
“These sustained carryover effects appear to be mediated by decreases in food intake that continued for the initial 2 weeks into the washout phase [26] and are similar to other findings in obese nonhuman primates that received fibroblast growth factor-21 [172,173], adipotide [174], or a melanocortin 4 agonist, BIM-2249…”
ResultOxytocin causes a long-term decrease of blood pressure in female and male rats
PETERSSON, M., ALSTER, P., LUNDEBERG, T., & UVNÄS-MOBERG, K. (1996) · Physiology & Behavior · doi:10.1016/s0031-9384(96)00261-2 · Cited by 229 · cited 2×
“Similarly, the effects of chronic intracerebroventricular (ICV) or subcutaneous administration of OT to reduce blood pressure persisted for nearly 10 days after OT treatment ended in male and female rats [177].”
BackgroundOxytocin Reduces Reward-Driven Food Intake in Humans
Ott, V., Finlayson, G., Lehnert, H., Heitmann, B., Heinrichs, M., Born, J., & Hallschmid, M. (2013) · Diabetes · doi:10.2337/db13-0663 · Cited by 226 · cited 4×
“In contrast, intranasal administration of OT, at a dose that reduced total caloric intake [34] and cookie consumption [35] and increased circulating levels of OT in other studies [167,168], failed to reduce plasma ghrelin [34,35], suggesting that this mechanism is not likely to contribute to the anorexigenic response…”
BackgroundResultInfluentialTreatment of obesity and diabetes using oxytocin or analogs in patients and mouse models
Zhang, H., Wu, C., Chen, Q., Chen, X., Xu, Z., Wu, J., & Cai, D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061477 · Cited by 224 · cited 9×
“Current data, however, suggest that the intranasal route of administration is not associated with unwanted side effects [220], including adverse effects on blood pressure or heart rate relative to vehicle treatment in rats [210], healthy adults [34,167,215] and pre-diabetic obese men and women [33].”
BackgroundResultInfluentialPeripheral oxytocin treatment ameliorates obesity by reducing food intake and visceral fat mass
Maejima, Y., Iwasaki, Y., Yamahara, Y., Kodaira, M., Sedbazar, U., & Yada, T. (2011) · Aging · doi:10.18632/aging.100408 · Cited by 220 · cited 7×
“Furthermore, chronic OT central or systemic infusions in vivo result in decreases in fat mass in mice and rats [27,28,30,32,62,93], including the adipocyte area from mesenteric [28], epididymal [28,62,151], subcutaneous [93], perirenal [93] and epicardiac [93] fat depots.”
BackgroundResultInfluentialPeripheral oxytocin suppresses food intake and causes weight loss in diet-induced obese rats
Morton, G. J., Thatcher, B. S., Reidelberger, R. D., Ogimoto, K., Wolden-Hanson, T., Baskin, D. G., Schwartz, M. W., & Blevins, J. E. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00296.2011 · Cited by 213 · cited 10×
“Furthermore, chronic OT central or systemic infusions in vivo result in decreases in fat mass in mice and rats [27,28,30,32,62,93], including the adipocyte area from mesenteric [28], epididymal [28,62,151], subcutaneous [93], perirenal [93] and epicardiac [93] fat depots.”
BackgroundResultInfluentialRecent advances in obesity-induced inflammation and insulin resistance
Tateya, S., Kim, F., & Tamori, Y. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2013.00093 · Cited by 211
Oxytocin revisited: Its role in cardiovascular regulation
Gutkowska, J., & Jankowski, M. (2012) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2011.02235.x · Cited by 208 · cited 1×
“In contrast, acute administration of OT into the CNS or periphery is associated with increases, decreases, or no changes in heart rate [71,210,221,222], blood pressure [177,210,223], and body temperature [71,221] in mice or rats (for review see [224,225]).”
BackgroundOxytocin reduces caloric intake in men
Lawson, E. A., Marengi, D. A., DeSanti, R. L., Holmes, T. M., Schoenfeld, D. A., & Tolley, C. J. (2015) · Obesity · doi:10.1002/oby.21069 · Cited by 208 · cited 7×
“In contrast, intranasal administration of OT, at a dose that reduced total caloric intake [34] and cookie consumption [35] and increased circulating levels of OT in other studies [167,168], failed to reduce plasma ghrelin [34,35], suggesting that this mechanism is not likely to contribute to the anorexigenic response…”
BackgroundInfluentialZhang, G., Bai, H., Zhang, H., Dean, C., Wu, Q., Li, J., Guariglia, S., Meng, Q., & Cai, D. (2011) · Neuron · doi:10.1016/j.neuron.2010.12.036 · Cited by 208
Young, L. J., & Barrett, C. E. (2015) · Science · doi:10.1126/science.aaa8120 · Cited by 200
Gossen, A., Hahn, A., Westphal, L., Prinz, S., Schultz, R. T., Gründer, G., & Spreckelmeyer, K. N. (2012) · Neuropeptides · doi:10.1016/j.npep.2012.07.001 · Cited by 189
Kendrick, K. M., Keverne, E. B., Baldwin, B. A., & Sharman, D. F. (2008) · Neuroendocrinology · doi:10.1159/000124638 · Cited by 187
Freeman, S. M., Inoue, K., Smith, A. L., Goodman, M. M., & Young, L. J. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.03.023 · Cited by 185 · cited 1×
“nucleus accumbens, preoptic area, VMH, DMV, and spinal cord) [73–75] and humans (e.”
BackgroundAn obligate role of oxytocin neurons in diet induced energy expenditure
Wu, Z., Xu, Y., Zhu, Y., Sutton, A. K., Zhao, R., Lowell, B. B., Olson, D. P., & Tong, Q. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045167 · Cited by 181 · cited 15×
“In addition, removal of approximately 95% of PVN OT neurons following Cre-mediated diphtheria toxin administration in adult oxytocin-Ires-Cre mice failed to impact intake of chow or HFDs [87].”
BackgroundInfluentialOLSON, B. R., DRUTAROSKY, M. D., STRICKER, E. M., & VERBALIS, J. G. (1991) · Endocrinology · doi:10.1210/endo-129-2-785 · Cited by 180
CSF and blood oxytocin concentration changes following intranasal delivery in macaque
Dal Monte, O., Noble, P. L., Turchi, J., Cummins, A., & Averbeck, B. B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103677 · Cited by 177 · cited 2×
“Given that circulating levels of OT are elevated by 40 or 60 min following intranasal administration in nonhuman primates [214] and humans [167,168,215] it is possible that intranasal OT is entering the circulation directly or indirectly following the release of endogenous OT into the CNS and peripheral circulation.”
BackgroundZhang, G., & Cai, D. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00196.2011 · Cited by 171 · cited 7×
“Furthermore, chronic OT central or systemic infusions in vivo result in decreases in fat mass in mice and rats [27,28,30,32,62,93], including the adipocyte area from mesenteric [28], epididymal [28,62,151], subcutaneous [93], perirenal [93] and epicardiac [93] fat depots.”
BackgroundInfluentialThe acute effects of intranasal oxytocin administration on endocrine and sexual function in males
Burri, A., Heinrichs, M., Schedlowski, M., & Kruger, T. H. C. (2008) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.01.014 · Cited by 168 · cited 3×
“In contrast, intranasal administration of OT, at a dose that reduced total caloric intake [34] and cookie consumption [35] and increased circulating levels of OT in other studies [167,168], failed to reduce plasma ghrelin [34,35], suggesting that this mechanism is not likely to contribute to the anorexigenic response…”
BackgroundBaroreflex control of heart rate by oxytocin in the solitary-vagal complex
Higa, K. T., Mori, E., Viana, F. F., Morris, M., & Michelini, L. C. (2002) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00806.2000 · Cited by 157 · cited 1×
“In contrast, direct injections of OT into the CNS increased energy expenditure [31,32,108], body temperature [71], and heart rate [71,135] in mice or rats.”
BackgroundTRIBOLLET, E., DUBOIS‐DAUPHIN, M., DREIFUSS, J. J., BARBERIS, C., & JARD, S. (1992) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1992.tb34343.x · Cited by 156 · cited 1×
“dorsal motor nucleus of the vagus (DMV), NTS or area postrema (AP)] [52,69–71], and spinal cord [72].”
BackgroundYamasue, H., Yee, J. R., Hurlemann, R., Rilling, J. K., Chen, F. S., Meyer-Lindenberg, A., & Tost, H. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.3327-12.2012 · Cited by 149 · cited 1×
“While the neurohypophyseal peptide oxytocin (OT) is well recognized for its role in lactation [18], uterine contraction [19], osmoregulation [20], and prosocial behavior [21,22], it has attracted interest as a therapeutic strategy to treat schizophrenia [21,23], autism spectrum disorder [21,22,24,25], and obesity [26–…”
BackgroundBremer, A. A., Stanhope, K. L., Graham, J. L., Cummings, B. P., Wang, W., Saville, B. R., & Havel, P. J. (2011) · Clinical and Translational Science · doi:10.1111/j.1752-8062.2011.00298.x · Cited by 148 · cited 1×
“dyslipidemia, weight gain, and visceral fat) in humans [7–12] and diet-induced obese (DIO) nonhuman primates following long-term exposure to high fructose diet [13].”
BackgroundIwasaki, Y., Maejima, Y., Suyama, S., Yoshida, M., Arai, T., Katsurada, K., Kumari, P., Nakabayashi, H., Kakei, M., & Yada, T. (2015) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00344.2014 · Cited by 148
Carson, D. S., Cornish, J. L., Guastella, A. J., Hunt, G. E., & McGregor, I. S. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.06.018 · Cited by 146 · cited 1×
“Systemic OT is capable of activating vagal afferents [105] where OTRs are expressed [60], inducing Fos within PVN OT neurons [179,213] and eliciting release of OT within the CNS [32] and likely back into the peripheral circulation.”
BackgroundGould, B. R., & Zingg, H. H. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00283-5 · Cited by 138
Loup, F., Tribollet, E., Dubois-Dauphin, M., Pizzolato, G., & Dreifuss, J. J. (1989) · Brain Research · doi:10.1016/0006-8993(89)90317-x · Cited by 136
Relative changes in resting energy expenditure during weight loss: a systematic review
Schwartz, A., & Doucet, É. (2010) · Obesity Reviews · doi:10.1111/j.1467-789x.2009.00654.x · Cited by 132
Aerosolized oxytocin increases cerebrospinal fluid oxytocin in rhesus macaques
Modi, M. E., Connor-Stroud, F., Landgraf, R., Young, L. J., & Parr, L. A. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.02.011 · Cited by 129 · cited 1×
“, Physiol Behav (2015), http://dx E D P R O O F In an effort to avoid unwanted peripheral side effects, some investigations have administered OT intranasally by nebulizer to allow for more targeted entry into the CNS without increasing circulating levels [214], but the data are mixed [226].”
BackgroundGault, V. A., Bhat, V. K., Irwin, N., & Flatt, P. R. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.512046 · Cited by 123
Oxytocin action in the ventral tegmental area affects sucrose intake
Mullis, K., Kay, K., & Williams, D. L. (2013) · Brain Research · doi:10.1016/j.brainres.2013.03.026 · Cited by 122 · cited 6×
“OT is released from somatodentrites within the SON and PVN, as well as distally at synaptic terminals on axons that originate from magnocellular PVN and SON projections to the neurohypophysis, as well as parvocellular PVN projections to CNS areas which include the arcuate nucleus (ARC) [56], ventral tegmental area (VT…”
BackgroundInfluentialAlteration of Glucose Homeostasis in V1a Vasopressin Receptor-Deficient Mice
Aoyagi, T., Birumachi, J.-I., Hiroyama, M., Fujiwara, Y., Sanbe, A., Yamauchi, J., & Tanoue, A. (2007) · Endocrinology · doi:10.1210/en.2006-1315 · Cited by 113
Hypothalamic Melanocortin Receptors and Chronic Regulation of Arterial Pressure and Renal Function
Kuo, J. J., Silva, A. A., & Hall, J. E. (2003) · Hypertension · doi:10.1161/01.hyp.0000048194.97428.1a · Cited by 113
Goldman, M. B., Gomes, A. M., Carter, C. S., & Lee, R. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2193-8 · Cited by 112 · cited 1×
“Regardless, it is encouraging that the intranasal route of administration has yielded positive prosocial effects in nonhuman primates [208], male and female individuals with schizophrenia [227,228], and in men and women who experience social rejection [229].”
BackgroundSchorscher-Petcu, A., Dupré, A., & Tribollet, E. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.06.016 · Cited by 111
Plasma oxytocin concentrations following MDMA or intranasal oxytocin in humans
Kirkpatrick, M. G., Francis, S. M., Lee, R., de Wit, H., & Jacob, S. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.04.006 · Cited by 106 · cited 2×
“Given that circulating levels of OT are elevated by 40 or 60 min following intranasal administration in nonhuman primates [214] and humans [167,168,215] it is possible that intranasal OT is entering the circulation directly or indirectly following the release of endogenous OT into the CNS and peripheral circulation.”
BackgroundPerlow, M. J., Reppert, S. M., Artman, H. A., Fisher, D. A., Self, S. M., & Robinson, A. G. (1982) · Science · doi:10.1126/science.7201163 · Cited by 105
Olszewski, P. K., Klockars, A., Olszewska, A. M., Fredriksson, R., Schiöth, H. B., & Levine, A. S. (2010) · Endocrinology · doi:10.1210/en.2010-0151 · Cited by 104 · cited 3×
“While consistent with studies showing that ingestion of sucrose and intralipid stimulates Fos (marker of neuronal activation) in PVN OT neurons [123], disruptions in OT signaling, however, do not consistently lead to increased consumption of chow, sucrose, and HFDs.”
BackgroundResultDistribution of oxytocin in the brain of a eusocial rodent
Rosen, G. J., de Vries, G. J., Goldman, S. L., Goldman, B. D., & Forger, N. G. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.05.039 · Cited by 102 · cited 1×
“bed nucleus of the stria terminalis medial preoptic area (MPA), anterior hypothalamus, medial amygdala, and subzona incerta) [54,55].”
BackgroundNoble, E. E., Billington, C. J., Kotz, C. M., & Wang, C. (2014) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00118.2014 · Cited by 102 · cited 8×
“While many such investigations have targeted the lateral, third, and fourth ventricles, the data show that OT reduces food intake following administration directly into the ARC [56], VMH [108], VTA [107] and NTS [88].”
BackgroundInfluentialProsocial effects of oxytocin in two mouse models of autism spectrum disorders
Teng, B. L., Nonneman, R. J., Agster, K. L., Nikolova, V. D., Davis, T. T., Riddick, N. V., Baker, L. K., Pedersen, C. A., Jarstfer, M. B., & Moy, S. S. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.04.038 · Cited by 98
Acute effects of intranasal oxytocin on subjective and behavioral responses to social rejection.
Alvares, G. A., Hickie, I. B., & Guastella, A. J. (2010) · Experimental and Clinical Psychopharmacology · doi:10.1037/a0019719 · Cited by 92 · cited 1×
“Regardless, it is encouraging that the intranasal route of administration has yielded positive prosocial effects in nonhuman primates [208], male and female individuals with schizophrenia [227,228], and in men and women who experience social rejection [229].”
BackgroundMaejima, Y., Rita, R. S., Santoso, P., Aoyama, M., Hiraoka, Y., Nishimori, K., Gantulga, D., Shimomura, K., & Yada, T. (2015) · Neuroendocrinology · doi:10.1159/000371636 · Cited by 81 · cited 2×
“While these findings are consistent with other reports of OT improving glucose tolerance in lean mice [83], DIO mice [28,32], DIO rats [27], and possibly normalweight [35] and obese humans [33], recent studies, however, indicate that chronic infusions of OT actually worsen glucose tolerance in ob/ob mice [62].”
BackgroundResultThe Promise and Perils of Oxytocin
Miller, G. (2013) · Science · doi:10.1126/science.339.6117.267 · Cited by 76 · cited 2×
“While no major deleterious effects on social behavior were reported following chronic intranasal administration of OT (at doses being used in clinical trials) in wild-type mice and a mouse model of autism spectrum disorder [241], additional studies should address the long-term neuroendocrine and behavioral effects fol…”
BackgroundHicks, C., Ramos, L., Reekie, T., Misagh, G. H., Narlawar, R., Kassiou, M., & McGregor, I. S. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12613 · Cited by 76
Hypothesis paper brain talks with fat-evidence for a hypothalamic-pituitary-adipose axis?
Schäffler, A., Binart, N., Schölmerich, J., & Büchler, C. (2005) · Neuropeptides · doi:10.1016/j.npep.2005.06.003 · Cited by 76
Hicks, C., Jorgensen, W., Brown, C., Fardell, J., Koehbach, J., Gruber, C. W., Kassiou, M., Hunt, G. E., & McGregor, I. S. (2012) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2012.02311.x · Cited by 73
Homologous regulation of brain oxytocin receptors.
Insel, T. R., Winslow, J. T., & Witt, D. M. (1992) · Endocrinology · doi:10.1210/endo.130.5.1315251 · Cited by 63
Relation between human vasopressin 1a gene variance, fat intake, and diabetes
Enhörning, S., Leosdottir, M., Wallström, P., Gullberg, B., Berglund, G., Wirfält, E., & Melander, O. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.26382 · Cited by 55
Wu, C.-L., Hung, C.-R., Chang, F.-Y., Francis Pau, K.-Y., & Wang, P. S. (2003) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-003-0690-y · Cited by 51
Vasopressin and oxytocin gene expression in the human hypothalamus
Sukhov, R. R., Walker, L. C., Rance, N. E., Price, D. L., & Young, W. S. (1993) · Journal of Comparative Neurology · doi:10.1002/cne.903370210 · Cited by 39
Ludwig, M., Tobin, V. A., Callahan, M. F., Papadaki, E., Becker, A., Engelmann, M., & Leng, G. (2013) · Journal of Neuroendocrinology · doi:10.1111/jne.12046 · Cited by 37 · cited 3×
“However, the extent to which this effect is due to elevations in exogenous or endogenous OT is being debated [162,210].”
BackgroundVila, G., Riedl, M., Resl, M., van der Lely, A. J., Hofland, L. J., Clodi, M., & Luger, A. (2009) · Journal of Endocrinology · doi:10.1677/joe-09-0227 · Cited by 31
Wu, C.-L., Doong, M.-L., & Wang, P. S. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.11.024 · Cited by 27 · cited 7×
“Based on the finding that circulating OT may act through central [106] or peripheral OTRs to reduce food intake [105,106] and the observation that peripheral administration can stimulate the release of CNS OT [32], further studies are needed to address the relevance of peripheral OTR signaling in the setting of diet-i…”
BackgroundInfluentialBorg, J., Simrén, M., & Ohlsson, B. (2011) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2010.01599.x · Cited by 26 · cited 1×
“These data are mixed, however, as peripheral treatment with OT has been reported to have no effect on gastric emptying rate in humans [157] and rats [158] or a stimulatory effect on gastric motility in rabbits, possibly due to species differences [159].”
ResultOxytocin receptors in non-human primate brain visualized with monoclonal antibody
Boccia, M. L., Panicker, A. K., Pedersen, C., & Petrusz, P. (2001) · Neuroreport · doi:10.1097/00001756-200106130-00041 · Cited by 21
Cited by
A rapidly acting glutamatergic ARC→PVH satiety circuit postsynaptically regulated by α-MSH
Fenselau, H., Campbell, J. N., Verstegen, A. M. J., Madara, J. C., Xu, J., Shah, B. P., Resch, J. M., Yang, Z., Mandelblat-Cerf, Y., Livneh, Y., et al. (2017) · Nature Neuroscience · doi:10.1038/nn.4442 · Cited by 233
Microbial lysate upregulates host oxytocin
Varian, B. J., Poutahidis, T., DiBenedictis, B. T., Levkovich, T., Ibrahim, Y., Didyk, E., Shikhman, L., Cheung, H. K., Hardas, A., Ricciardi, C. E., et al. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.11.002 · Cited by 153
“…has been shown to accelerate wound healing (Gavrilenko et al., 2003; Gouin et al., 2010; Vitalo et al., 2009), counteract obesity (Barengolts, 2016; Blevins and Baskin, 2015), suppress uncontrolled inflammation (Wang et al., 2015) and prevent muscle wasting (Costa et al., 2014; Elabd et al., 2014)…”
What's Love Got to do with it: Role of oxytocin in trauma, attachment and resilience
Sharma, S. R., Gonda, X., Dome, P., & Tarazi, F. I. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107602 · Cited by 61
Undurti, A., Colasurdo, E. A., Sikkema, C. L., Schultz, J. S., Peskind, E. R., Pagulayan, K. F., & Wilkinson, C. W. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00072 · Cited by 44
Quintana, D. S., Dieset, I., Elvsåshagen, T., Westlye, L. T., & Andreassen, O. A. (2017) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2016.12.004 · Cited by 39
Metadata
- Authors
- Blevins, J. E., & Baskin, D. G.
- Venue
- Physiology & Behavior
- Publisher
- Elsevier BV
- Published
- 2015-12
- Volume
- 152
- Issue
- Pt B
- Pages
- 438-449
- ISSN
- 0031-9384 (ISSN-L)
- OpenAlex
- W2194605942
- Cited by
- 134
- References
- 96
- FWCI
- 8.33
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.